The Alliance of Community Health Plans (ACHP) submitted a letter to the Centers for Medicare & Medicaid Services (CMS) about the National Coverage Determination (NCD) for beta amyloid pet scans in dementia and neurodegenerative disease patients.
With promising but uncertain treatments of Alzheimer’s actively in development, testing and early usage, now is not the appropriate time to change an NCD that has been in place and working since 2013.
New from ACHP:
- Chronic Disease Pledge Bright Spot: UPMC Health Plan Behavioral Health Coaching
- ACHP Letter to Congress on Year-End Priorities
- ACHP Letter to CMS on Medicaid Capitation Rate Adjustments
- ACHP Welcomes Two New Members, Celebrates Strength of Nonprofit Health Plans
- The Directory Dilemma: Challenges and Solutions for Accurate Provider Directories
- ACHP Responds to Congressional RFI on Emerging Therapies and Health Information Technology
